The Pathogenetic Basis of the Action of Bempedoic Acid
The modern cardiology has a wide range of medications which affect various pathogenetic links of atherosclerosis, but even the best of them still obtain disadvantages causing intolerance and medicine discontinuation. The development of new hypolipidemic medications will allow not only to introduce a...
Saved in:
Main Authors: | A. S. Petrosyan (Author), R. S. Rud' (Author), P. P. Polyakov (Author), A. Kh. Kade (Author), S. A. Zanin (Author) |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bempedoic Acid in Secondary Prevention
by: Idine Mousavi, et al.
Published: (2024) -
Bempedoic acid for the treatment of dyslipidemia
by: Joel C Marrs, et al.
Published: (2020) -
Bempedoic Acid for Heterozygous Familial Hypercholesterolemia: From Bench to Bedside
by: Agarwala A, et al.
Published: (2021) -
Pharmacokinetics of bempedoic acid in patients with renal impairment
by: Benny M. Amore, et al.
Published: (2022) -
Bempedoic Acid: Safety and Efficiacy of a New Lipid-Lowering Agent
by: I. A. Mazerkina, et al.
Published: (2023)